"Asian Countries to Witness Tremendous Growth in Future"

Interview "Asian Countries to Witness Tremendous Growth in Future"

29.04.2013Author / Editor: The interview is conducted by Assistant Editor, PROCESS India, Swati Deshpande. / Dominik Stephan

Sigma-Aldrich has recently opened a Global Shared Services (GSS) Center at Bengaluru. Jason Apter, Vice President & Managing Director Asia Pacific, Sigma Aldrich talks to PROCESS India about company’s GSS Center and plans ahead.

Related Companies

MilliporeSigma SIGMA-ALDRICH Chemie GmbH

MilliporeSigma

Maag Pump Systems AG

GIG Karasek GmbH

EPC Group

“We suspect that biosimilars is going to see a very strong future and India is going to be one of the major hubs in this section,” Apter
(Picture: Vogel Business Media)

PROCESS: Can you throw some light on the recently opened Global Shared Services (GSS) Center?

JASON APTER: The newly opened GSS Center will offer services such as strategic marketing, sales support and business analytics to both our international and domestic customers.

From transactional to highly strategic responsibilities, our GSS India employees will help support the global business growth and accelerate operational excellence. With its high rate of growth, India remains our major focus. With GSS, we will leverage our capabilities, talent and infrastructure in India to better serve our businesses.

Gallery

“Amidst of all opportunities and challenges, how a company survives and sustains is more important than talking merely about the problems. That’s how one succeeds.” - Jason Apter

PROCESS: How do you see the growth of the Indian pharmaceutical and life sciences industry?

"Pharma and Life Sciences Are Growing Well in Asia–Pacific

JASON APTER: The whole of the Asia Pacific market plays an important role in our company’s growth. As a result, we have invested in this region to a great extent in the last few years.

Our company has opened a packaging facility in Bengaluru, a facility in Wuxi, China, which is fully operational and has recently completed a SAFC Hitech precursor manufacturing facility in Taiwan. Therefore, it becomes needless to say that the pharma and life sciences sectors are growing well in the Asia Pacific region including India.

PROCESS: What products and solutions have higher demand in India?

JASON APTER: It is a difficult question to answer as our company offers more than 100,000 products. Hence, it is going to be difficult to have a comparison on the parameters of products. However, there are a few industry segments that have been growing in the country viz. segments such as analytical products, biology products, chemistry products, material science products. All these have a higher demand in India.

Unfold for details of your consent

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

(ID:39391530)

Interview "Asian Countries to Witness Tremendous Growth in Future"

"Pharma and Life Sciences Are Growing Well in Asia–Pacific

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Consent to the use of data for promotional purposes